Sex Differences in Alzheimer's Disease

Neurol Clin. 2023 May;41(2):343-358. doi: 10.1016/j.ncl.2023.01.001.

Abstract

Reviewing the research presented in this article, it is evident that from an epidemiological perspective, it is important to evaluate the extent to which findings of sex and gender differences in Alzheimer's dementia (AD) are due to differences in longevity, survival bias, and comorbidities. Medical, genetic, psychosocial, and behavioral factors, in addition to hormonal factors, can differentially affect the risk and progression of AD in women versus men. Further, evaluation of sex differences in AD progression and the trajectory of change in cognitive function, neuroimaging, cerebrospinal fluid (CSF), and blood-based biomarkers of AD is needed. Finally, identifying sex differences in AD biomarkers and change across the lifespan is critical for the planning of prevention trials to reduce the risk of developing AD.

Keywords: Alzheimer’s dementia; Biomarkers; Cognitive decline; Risk factors; Sex differences.

Publication types

  • Review
  • Research Support, N.I.H., Extramural

MeSH terms

  • Alzheimer Disease* / diagnosis
  • Alzheimer Disease* / epidemiology
  • Biomarkers
  • Disease Progression
  • Female
  • Humans
  • Male
  • Sex Characteristics
  • Sex Factors
  • tau Proteins

Substances

  • Biomarkers
  • tau Proteins